FasL+PD‐L2+ Identifies a Novel Immunosuppressive Neutrophil Population in Human Gastric Cancer That Promotes Disease Progression
Authors:
Open Access
- 26 December 2021
- journal article
- research article
- Published by Wiley in Advanced Science
- Vol. 9 (5) , 2103543
Abstract
Neutrophils constitute abundant cellular components in human gastric cancer (GC) tissues, but their protumorigenic subset in pathogenesis of GC progression is unclear. Here, it is found that patients with GC show significantly higher neutrophil infiltration in tumors that is regulated by CXCL12‐CXCR4 chemotaxis. These tumor‐infiltrating neutrophils express high level immunosuppressive molecules FasL and PD‐L2, and this FasL+PD‐L2+ neutrophil subset with a unique phenotype constitutes at least 20% of all neutrophils in advanced GC and predicts poor patient survival. Tumor induces neutrophils to express FasL and PD‐L2 proteins with similar phenotype to those in GC tumors in both time‐dependent and dose‐dependent manners. Mechanistically, Th17 cell‐derived IL‐17A and tumor cell‐derived G‐CSF can significantly induce neutrophil FasL and PD‐L2 expression via activating ERK‐NF‐κB and JAK‐STAT3 signaling pathway, respectively. Importantly, upon over‐expressing FasL and PD‐L2, neutrophils acquire immunosuppressive functions on tumor‐specific CD8+ T‐cells and promote the growth and progression of human GC tumors in vitro and in vivo, which can be reversed by blocking FasL and PD‐L2 on these neutrophils. Thus, the work identifies a novel protumorigenic FasL+PD‐L2+ neutrophil subset in GC and provides new insights for human cancer immunosuppression and anti‐cancer therapies targeting these pathogenic cells.Keywords
Funding Information
- National Natural Science Foundation of China (81872016, 82003039, 81902922, 82070578, 81870394, 81670510)
- National Key Research and Development Program of China (2016YFC1302200)
This publication has 34 references indexed in Scilit:
- The Prognostic Value of Tumor-Infiltrating Neutrophils in Gastric Adenocarcinoma after ResectionPLOS ONE, 2012
- Tumor-Associated Neutrophils: New Targets for Cancer TherapyCancer Research, 2011
- The colony-stimulating factors and cancerNature Reviews Cancer, 2010
- TH17 cells in tumour immunity and immunotherapyNature Reviews Immunology, 2010
- The Yin-Yang of Tumor-Associated NeutrophilsCancer Cell, 2009
- Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1Journal of Experimental Medicine, 2009
- Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patientsJournal of Hepatology, 2009
- The Many Roles of FAS Receptor Signaling in the Immune SystemImmunity, 2009
- Immunosuppressive networks in the tumour environment and their therapeutic relevanceNature Reviews Cancer, 2005
- The role of Fas ligand in immune privilegeNature Reviews Molecular Cell Biology, 2001